TipRanks
Go Ultimate55% OFF

Lineage Therap (BT3) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

BT3 Analyst Ratings

Strong Buy
4Ratings
4Buy0Hold0Sell
Based on 4 analysts giving stock ratings to Lineage Therap in the past 3 months

BT3 Stock 12 Month Forecast

EUR 5.60▲(544.23% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Lineage Therap in the last 3 months. The average price target is EUR 5.60 with a high forecast of EUR 8.07 and a low forecast of EUR 2.69. The average price target represents a 544.23% change from the last price of EUR 0.87.
Highest Price TargetEUR 8.07Average Price TargetEUR 5.60Lowest Price TargetEUR 2.69

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:BT3
Price TargetFollowArticle
H.C. WainwrightEUR 6.28→EUR 8.07buy827.69%UpsideReiterated10/29/26
B. Riley SecuritiesEUR 3.59buy312.31%UpsideReiterated09/24/26
Maxim GroupEUR 2.69buy209.23%UpsideReiterated08/11/26
Canaccord GenuityEUR 8.07buy827.69%UpsideReiterated08/06/26
Craig-Hallum―buy―Reiterated07/14/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Lineage Therap

3 Months
Success Rate8/14 ratings generated profit
57%
Average Return
+28.76%

Copying Michael Okunewitch's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +28.76% per trade.

1 Year
Success Rate8/14 ratings generated profit
57%
Average Return
+58.59%

Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +58.59% per trade.

2 Years
Success Rate9/14 ratings generated profit
64%
Average Return
+23.51%

Copying Michael Okunewitch's trades and holding each position for 2 Years would result in 64.29% of your transactions generating a profit, with an average return of +23.51% per trade.

BT3 Analyst Recommendation Trends

05101520Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for BT3
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy56455
Buy01110
Hold00000
Sell00000
Strong Sell00000
total57565

In the current month, BT3 has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BT3 average Analyst price target in the past 3 months is 5.60.

BT3 Financial Forecast

EUR -2EUR -1.25EUR -0.5EUR 0.25EUR 1Q4 2025Q2 2026Q3 2026
HighEUR 0.00
ConsensusEUR -0.03
LowEUR -0.04

BT3 Earnings Forecast

Next quarter’s earnings estimate for BT3 is -EUR 0.03 with a range of -EUR 0.04 to EUR 0.00. The previous quarter’s EPS was -EUR 0.03. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

EUR 951,002EUR 2.4MEUR 3.8MEUR 5.2MEUR 6.7MQ4 2025Q2 2026Q3 2026
HighEUR 6.67M
ConsensusEUR 2.06M
LowEUR 951K

BT3 Sales Forecast

Next quarter’s sales forecast for BT3 is EUR 2.06M with a range of EUR 951.00K to EUR 6.67M. The previous quarter’s sales results were EUR 951.00K. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

BT3 Stock Forecast FAQ

What is DE:BT3’s average 12-month price target, according to analysts?
Based on analyst ratings, Lineage Therap’s 12-month average price target is €5.60.
What is DE:BT3’s upside potential, based on the analysts’ average price target?
Lineage Therap has 544.23% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Lineage Therap a Buy, Sell or Hold?
Lineage Therap has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Lineage Therap’s share price target?
The average share price target for Lineage Therap is €5.60. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €8.07, and the lowest forecast is €2.69. The average share price target represents a 544.23% increase from the current price of €0.87.
What do analysts say about Lineage Therap?
Lineage Therap’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Lineage Therap?
To buy shares of DE:BT3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.